Additionally, some studies have shown that taking ART for less than one year is a risk factor for ESBL incidence, and the risk of infection with ESBL-producing pathogens among HIV-positive individuals varies according to the CD4 count and is greatest in HIV-positive individuals with CD4 counts <350 cells/mm3. The gene discussed is CD4; the disease is infection.